What Avenues does

Avenues (The Avenues Company) is a boutique professional services firm headquartered in Flagstaff, Arizona, providing integrated marketing services to the medical device, pharmaceutical, diagnostics, and biotechnology sectors. With a 1-10 employee footprint, the firm operates a service-only engagement model rather than a packaged-product model and is led by Jeanne Ambruster (CEO since 2001) and Francine Berkey (President since 1999). Its therapeutic specialization spans tissue regeneration, osseointegration, wound healing, and inflammation across medical and dental indications, reflecting the founders' background in translating scientific discovery into clinical and commercial practice.

The firm's offering encompasses eleven interconnected practices: Vision Development & Strategy, Market Research & Analysis, Product Launches, Advisory Boards, Clinical & Regulatory Services, Business Development, Training Programs, Meeting Planning & Execution, Organizational Development, Technical Writing & Publications, and New Product Pipeline Development. Client categories include medical device manufacturers, biologics firms, diagnostics companies, pharmaceutical companies, and professional organizations. Pricing is not publicly disclosed and engagements appear to be project-based consulting tailored to each client's position in the product lifecycle.

The business model is relationship-driven and built on the founders' personal expertise and networks. Ambruster's tenure follows a career that included building the global regenerative technologies business at W.L. Gore's Medical Division, and Berkey's PhD in Organizational Communication anchors the firm's relationship-based marketing, market research facilitation, and organizational planning practices. Go-to-market is direct B2B into mid-market and specialty life sciences companies, monetizing senior practitioner time rather than recurring seats or transaction volumes.

Name

Avenues

Legal name

AvenuesAI Limited

Website

https://theavenuescompany.com

Company type

Public

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

Avenues is a boutique marketing services firm based in Flagstaff, Arizona, providing integrated strategy, market research, clinical/regulatory, and commercialization services to medical device, pharmaceutical, diagnostics, and biotechnology clients.

Ownership category

akta.pro rank

Headquarters

HQ city

Flagstaff

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Payment Processing Services: The payments business contributed 97.5% of total collections with collections jumping 130% year-on-year to Rs 2,323 crore. Payment volume grew 69% to INR 1,361 billion transactions. This is the dominant revenue stream for AvenuesAI.
2. Enterprise Software Platform Services: The company provides enterprise software platform services to business clients, contributing to revenue diversification alongside core payment services.
3. Digital Payments Expansion: Revenue growth driven by expansion in digital payments services, with the company transitioning from legacy internet portal to AI-driven digital platform.

Go-to-market motion2 records

Distribution channels2 records

Core offering

Avenues is a boutique marketing services firm serving medical device, pharmaceutical, diagnostics, and biotechnology clients. The firm delivers an integrated portfolio of eleven service offerings spanning strategy (Vision Development, Market Research, Pipeline Development), execution (Product Launches, Advisory Boards, Clinical & Regulatory Services, Training Programs, Meeting Planning, Technical Writing), and organizational support (Business Development, Organizational Development), each tailored to clients' specific needs and designed to work in concert from concept to completion.

Product overview

The Avenues Company is an innovative marketing services firm specializing in medical devices, pharmaceuticals, diagnostics and biotechnology. The company operates as a single integrated service platform rather than a product-based company. Their service portfolio encompasses eleven core offerings: Vision Development & Strategy, Market Research & Analysis, Product Launches, Advisory Boards, Clinical & Regulatory Services, Business Development, Training Programs, Meeting Planning & Execution, Organizational Development, Technical Writing & Publications, and New Product Pipeline Development. These services are tailored to each client's specific needs and are designed to work in an integrated manner from concept to completion, with particular expertise in tissue regeneration, osseointegration, wound healing and inflammation across medical and dental indications.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical & Regulatory Services Provides specific clinical and regulatory services that help medical device, pharma, and biotech clients improve product adoption by integrating this phase as early as possible in the development process with a market-driven approach.
• Business Development Uses Avenues' extensive life sciences industry knowledge and relationships to assist clients in developing business development strategies, finding ideal partners, and negotiating favorable deal structures.
• Market Research & Analysis Conducts market research through online, traditional mail, and phone surveys, focus group sessions, and in-depth interviews, developing customized market research reports and decision tools for life sciences clients.
• Product Launches Works with clients on successful new product launches in medical devices, pharmaceuticals, diagnostics, and biotechnology, accelerating and optimizing product adoption by injecting marketing know-how and key relationships into the program as early in the development cycle as possible.
• Advisory Boards Provides planning, facilitating, documenting, and integrating outcomes of advisory board meetings in order to maximize the return on investment in these pivotal events for life sciences clients.
• Training Programs Develops training programs and materials, including working with physician/dentist speakers and universities as well as with consultative sales organizations to support message and messenger development for life sciences clients.
• Meeting Planning & Execution Provides planning, logistics, facilitation, and documentation services for consensus meetings, thought leader meetings, symposia, and other educational events using innovative techniques and interactive technologies.
• Organizational Development Provides specific expertise in organizational development and team building, including successful planning and facilitation of innovative leadership training and communication workshops for life sciences clients.
• Technical Writing & Publications Assists life sciences clients with their technical writing needs for in-house purposes and for articles being submitted to professional journals.
• New Product Pipeline Development Combines technical and regulatory knowledge with an understanding of market dynamics and clinical needs to assist clients in setting priorities and developing optimal product pipelines.
• Vision Development & Strategy Supports clients with vision development and strategic planning utilizing techniques such as environmental scans, SWOT analyses, polarity management, and right-to-left planning.

Quantifiable outcome

• 122% revenue growth in Q3 FY2025 to INR 23,812 million
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Rediff.com India LimitedcoreChannel Partner/ Reseller/ Distributor · 1 January 2024Rediff.com India Limited is a subsidiary of AvenuesAI following acquisition in 2024. The company is transitioning from a legacy internet portal to an AI-driven digital platform and has filed for an IPO to raise Rs 600-800 crore. Rediff plans to launch RediffPay as a B2C platform.

Scale indicators10 records

Direct peers

• Dudnyk: Healthcare-focused marketing agency specializing in specialty pharma, biotech, medical devices and diagnostics. Closely comparable to Avenues in target buyer (medical marketers, brand teams) and service model (integrated strategy, creative and launch support).
• AbelsonTaylor: Independent healthcare advertising and marketing agency serving pharma, biotech and medical device clients. Comparable to Avenues in its dedicated healthcare focus, brand launch expertise and integrated service offerings.
• The Lockwood Group: Medical communications and consulting firm serving pharmaceutical, biotech and medical device companies. Comparable to Avenues in offering medical affairs, advisory board facilitation, publications and strategic consulting to specialty healthcare clients.
• Real Chemistry: Healthcare marketing and communications firm serving pharma, biotech and medical device companies. Comparable to Avenues in providing integrated strategy, brand, medical communications and commercialization support.
• Harrison and Star: Healthcare advertising agency focused on specialty pharma and biotech launches. Comparable to Avenues in providing launch strategy, brand development and medical marketing services to specialty therapeutic clients.

Broad incumbents

• IQVIA: Global life sciences technology and consulting firm with a healthcare commercialization practice. Comparable to Avenues in offering market research, advisory board facilitation and brand strategy to medical device and pharma clients, though at vastly greater scale.
• ZS Associates: Global management consulting and technology firm with a dedicated healthcare practice serving pharma, biotech and medical devices. Comparable to Avenues in its life-sciences strategy and commercialization focus, but with broader services and global scale.
• Syneos Health: Large contract research and commercialization organization serving pharma and biotech. Comparable to Avenues as it also provides medical affairs, brand consulting and product launch support, though across a much broader portfolio and scale.
• McKinsey & Company (Healthcare Practice): Global management consulting firm with a major healthcare practice serving medical device, pharma and biotech clients. Comparable to Avenues in the strategy and operational consulting layer, though with dramatically broader scope, scale and international reach.

Emerging players

• Precision Medicine Group: Specialty services company supporting biotech and pharma clients across medical affairs, market access and commercial services. Comparable to Avenues in the niche life-sciences focus and integrated commercialization support model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/the-avenues-company

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avenues